Pınar, İ. E. And Ozkocaman, V. 2023. Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. The European Research Journal , vol.9, no.6 , 1483-1492.

Pınar, İ. E., & Ozkocaman, V., (2023). Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma. The European Research Journal , vol.9, no.6, 1483-1492.

Pınar, İBRAHİM, And VİLDAN ÖZKOCAMAN. "Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma," The European Research Journal , vol.9, no.6, 1483-1492, 2023

Pınar, İBRAHİM E. And Ozkocaman, VİLDAN. "Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma." The European Research Journal , vol.9, no.6, pp.1483-1492, 2023

Pınar, İ. E. And Ozkocaman, V. (2023) . "Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma." The European Research Journal , vol.9, no.6, pp.1483-1492.

@article{article, author={İBRAHİM ETHEM PINAR And author={VİLDAN ÖZKOCAMAN}, title={Efficacy and safety outcomes of single-agent ibrutinib therapy in chronic lymphocytic leukemia and relapsed/refractory mantle-cell lymphoma}, journal={The European Research Journal}, year=2023, pages={1483-1492} }